R. Bert Wilkins, JD, MHA, CIP
Regulatory Chair Director, WCG
Biography
R. Bert Wilkins is one of the Regulatory Chair Directors WCG Institutional Review Board (WCG IRB). Bert has been working for IRBs since 2007. In this role, Bert advises the IRB on appropriateness and regulatory aspects of a wide array of research such as FDA regulated studies, Social/Behavioral Health research, International research, Emergency Research, and research involving vulnerable subjects.
Bert earned a BS from University of Washington, a MHA from University of North Carolina at Chapel Hill, and then a JD from Seattle University.
Latest insights by R. Bert
							
			Ethics in Clinical Research
			
	
		
		Answering FAQs on HIPAA & PHI: Protect Participants’ Privacy & Ensure Compliance
Blog Posts
							
			Ethics in Clinical Research
			
	
		
		Review of Emergency Research
Whitepapers
							
			Ethics in Clinical Research
			
	
		
		A Review Of The Regulatory Landscape for In Vitro Gametogenesis
Blog Posts
							
			FDA & ICH
			
	
		
		Function over Form: Assessing Different Consent Form Formats
Whitepapers
							
			Ethics in Clinical Research
			
	
		
		Should Parents Be Allowed to View their Child’s Survey Responses?
Blog Posts
							
			Ethics in Clinical Research
			
	
		
		Ethical and Regulatory Considerations in Patient-to-Patient-Referral Recruitment Plans
Whitepapers
							
			Clinical Endpoints
			
	
		
		Do You Know Me?: The Subtle Distinction Between “Anonymous” and “De-identified” Data in Clinical Research
Whitepapers